Medifast's Third-Quarter Revenue Fell 36%: Is Stabilization Near?

Medifast reported a sharp revenue decline in Q3 FY2025, with sales down 36.2% to $89.4 million driven by a 35% drop in active earning OPTAVIA coaches to 19,500 and a 1.9% decline in revenue per active coach to $4,585. Management implemented rightsizing in October to protect margins and expects coach growth to re-emerge in roughly 6–9 months with an inflection in Q4 FY2025; investments in pricing programs and digital tools aim to stabilize coach productivity into 2026. External metrics remain weak—MED carries a Zacks Rank #4, trades at a forward P/S of 0.35 versus industry 1.05, and consensus EPS estimates imply a steep current-year decline—indicating continued downside risk for the equity in the near term.

Analysis

Market structure: MED’s 36% y/y revenue decline and 35% drop in active earning coaches crystallize that coach-driven, direct-selling weight-loss models are the immediate losers; branded CPG and beverage names with stable retail distribution (COCO, MNST, UNFI) are relative winners as share shifts to retail/omnichannel. Pricing power will be constrained at MED until coach base stabilizes; inventory/supply is not the bottleneck — demand (coach recruitment + activation) is. Cross-asset: MED equity implied vol will stay elevated; expect wider equity and single-name CDS spreads for small-cap consumer names and modest negative carry into high‑yield credit if leverage exists; FX/commodities impact immaterial.

Risk assessment: Tail risks include accelerated coach attrition (>50% further), a legal/regulatory probe into MLM practices, or covenant breaches if revenue slide continues for two more quarters — each could cause >50% downside. Immediate (days) risk: headline-driven selloffs; short-term (weeks–months): margin benefits from rightsizing may show but only if coach churn stops within 6–9 months; long-term (quarters–years): recovery depends on digital adoption and coach LTV improvement. Hidden dependencies: coach incentives/CAC, digital app engagement, and EDGE program adoption rates drive recovery speed. Key catalysts: next two quarterly coach counts, revenue per coach trends, and any activist or restructuring announcements.

Trade implications: Direct play — initiate a tactical short in MED sized 0.5–1.5% of portfolio via equity or 3–6 month put spreads (target 30–50% downside if coach attrition continues). Pair trade — long COCO or MNST (1–2% each) vs short MED (0.5–1%) to capture share rotation into retail-branded CPG. Options — buy MED 3–6 month ATM put or bear put spread to limit premium; consider long calls on COCO/MNST 6–12 months out if buying shares is constrained. Rotate portfolio from coach-dependent consumer health into resilient branded staples and distributors now; enter within 1–3 weeks and scale against KPI readouts.

Contrarian angles: Consensus may be over-discounting recovery potential — MED’s forward P/S 0.35 implies extreme downside priced in; if active coach decline stabilizes within 4–6 months and per-coach revenue turns +2–5%, upside could be rapid. Historical parallel: WW’s digital pivot produced outsized recovery once membership stabilization occurred; similarly, MED’s app/EDGE could accelerate LTV. Unintended consequence of the beaten-down price: activist interest or opportunistic M&A at depressed multiples — a mean‑reversion catalyst to monitor over 6–12 months.

Key Decisions for Investors

• Establish a tactical short position in MED sized 0.5–1.5% of portfolio via equity or a 3–6 month bear put spread; size to risk no more than 1.5% notional and target 30–50% downside if coach attrition persists beyond next two quarters.
• Initiate 1–2% long positions in COCO and MNST (0.5–1% each) to capture rotation into retail-branded CPG; prefer 6–12 month horizon and scale up on any MED-driven market weakness.
• Implement a pair trade: long MNST (1%) / short MED (0.5–1%) to express relative strength in branded beverages versus coach-driven weight-loss, enter within 2 weeks and rebalance after two consecutive quarterly KPIs show improvement.
• Use options to express views with limited risk: buy 3–6 month ATM puts on MED (or a -10/-25% bear put spread) sized to 0.5–1% risk, and buy 6–12 month calls on COCO or MNST if wanting leveraged upside (limit to 0.5–1% premium spend).
• Exit or reduce short exposure if MED reports two consecutive quarters of (a) active earning coach count stabilization or growth, and (b) sequential revenue per active coach growth >2%; otherwise reassess at 6–12 months. Monitor coach counts, revenue per coach, gross margin, and any regulatory/activist filings weekly for 90 days.